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Injury is the leading cause of mortality in many coun-tries and in the younger age group especially, andtraumatic brain injury (TBI) is responsible for the
majority of these deaths. The global average morbidity
of TBI is reported as 200 persons in 100 000 population
(different countries ranging from 91 to 430 per 100 000)
with a mortality of 20 per 100 000 (9-89 per 100 000).1 The
latest epidemiological data revealed an estimated 1.1
million emergency department visits, 235 000
hospitalizations, and 50 000 deaths annually only in
the United States each year due to TBI. The main
causes of TBI are motor vehicle accidents, falls and
gunshot injuries in the USA.2 As for the consumption of
social cost to traffic trauma in China, it is about 1.5%
of the whole gross national product (GNP).3 But the
official statistical data about incidence of TBI are not
comprehensive in China. Based on the big population
in China, the reported data may underestimate the true
burden and harmfulness of TBI to Chinese society.
The Glasgow coma scale (GCS) gives a numerical
value to the three most important parameters of the
level of consciousness—opening of the eyes, best ver-
bal response and best motor response. TBI is com-
monly categorized by means of a numerical score—
the sum of the three parameters of the GCS as severe
(GCS≤8), moderate (GCS 9-13) and minor (GCS14-
15) TBI.4 Severe TBI accounts for approximately 10%
of all brain injury patients, whereas moderate TBI ac-
counts for another 10%; the remaining 80% are classi-
fied as minor TBI.5 However, increasing clinical evi-
dences indicate that injuries that are apparently similar
may have very different severities and outcomes, and
more and more people have realized that the severities
and outcomes are quite variable and not fully explained
by the known factors (such as age, severity of injury
and treatments, etc.).6 It is now demonstrated that ge-
netic polymorphism may play a key role in the suscep-
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Traumatic brain injury (TBI) is defined as an injury
caused by a blow or jolt to the head or a penetrating head
injury that disrupts the normal function of the brain. It is a
common emergency and severe case in neurosurgery field.
Nowadays, there are more and more evidences showing
that TBI, which is apparently similar in pathology and se-
verity in the acute stage, may have different outcomes. The
known prognostic factors (such as age, severity of injury
and treatments, etc.) explain only part of this variability and
the concept of genetic susceptibility of traumatic brain in-
jury has already been accepted by more and more people. It
is now demonstrated that genetic polymorphism may play a
key role in the susceptibility to TBI, even outcome follow-
ing TBI. Although there are many genes that may involved
in pathophysiological processes influencing TBI,
apolipoprotein E gene has become one of the most exten-
sive studied genes in neurotrauma and neurodegenerative
disease and seems to take an important part in the neural
responses to TBI. In this article, we will review the current
understanding of the genetic susceptibility of TBI and the
advancements regarding the impact of apolipoprotein E
genotype on the severity and/or outcome following TBI.
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tibility to TBI, even outcome after TBI. 7,8 In this article,
we will review the current understanding of the genetic
susceptibility of TBI and the advancements regarding
APOE genotype influences on the severity and/or out-
come following TBI.
Genetic susceptibility to TBI
In neurosurgery field, TBI is a common emergency
disease. Because TBI is a random event, many people
think that TBI is independent of genetic factors.
However, more and more evidences have shown that
TBI, which is apparently similar in pathology and sever-
ity in the acute stage may have different outcomes.
The phenomenon of genetic susceptibility to brain
injuries was first noticed in the animal studies. Initial
researches found that different species and strains of
rodents have different susceptibilities to neurodegener-
ative insults or other brain injuries, but further studies
have not been carried out until recent 10 years. The
earlier research performed systematically by Schau-
wecker and Steward 9 in 1997 found dramatic differenc-
es between different strains of mice in their susceptibil-
ity to hippocampal lesions caused by kainic acid–in-
duced status epilepticus. C57BL/6, BALB/c, C3H, and
129SvJ mice exhibited relatively little cell death in the
hippocampus after systemic kainic acid injection while
FVB/N, DBA/2J, 129SvEMS, and CD1 mice showed
massive hippocampal neuronal loss, even though there
was no difference in the severity or duration of the be-
havioral seizures during the acute period among the
strains of mice. Thereafter a similar study, which as-
sessed the impact of genetic background on mouse
strain seizure susceptibility, seizure phenotype,
mortality, and hippocampal histopathology, found that
C3HeB/FeJ and C57BL/6J strains were resistant to cell
death and synaptic reorganization despite severe be-
havioral seizures, while 129/SvEms mice developed
marked pyramidal cell loss and mossy fiber sprouting
despite limited seizure activity. The mixed background
129/SvJXC57BL/6J group exhibited features of both
parental strains.10 A series of studies focusing on these
fields has been investigated to provide the evidences
supporting the hypothesis that genetic factor may play
an important role in the traumatic brain responses. 11,12
In China, the Research Institute of Field Surgery of
Third Military Medical University put forward the con-
cept of heterogeneity of traumatic responses for the
first time in traumatic field. Feng et al.13 observed the
posttrauma-response heterogeneity between the
C57BL/6 and BALB/C inbred mice after the two strains
of mice were injured by the same blast wave. The sig-
nificant differences in the mortality rates and the sever-
ity of lung injury between the C57BL/6 and BALB/C
inbred mice within 72 hours were found, which might
reflect the differences of their genetic background. In
their subsequent researches, the up-regulated expres-
sion of a new gene after TBI was identified, which was
designated as Gene Brain Injury (GBI) located on the
chromosome 6 (6E3) of mice. There was significant
difference in expression of GBI after injury between the
C57BL/6 mice group and BALB/C mice group. Though
BALB/C mice’s brain showed higher expression of GBI
than C57BL/6 mice brain before the blast injury, C57BL/6
mice group exhibited quicker and higher expression of
GBI (peaked at 1 h after brain injury) than BALB/C mice.
In recent years, more and more Chinese researchers
pay attention to the genes and correlated expression
products which affect the pathophysiological respon-
dence of TBI.  The effects of several genes including
Apolipoprotein E gene, bcl-2 gene family, caspase gene
family and IL-6 gene etc. on severities and/or outcomes
following TBI have been investigated. 8,14 15,16 Despite late
start, the progress in this field is quite fast in China and
the concept of genetic susceptibility to TBI will be rec-
ognized by more scholars and doctors.
Apolipoprotein E
Apolipoprotein E (apoE) is one of lipoproteins and
an important mediator of cholesterol and lipid transport
in the brain, which is believed to play a key role in the
repair of damaged neurons by mediating the recycling
of cell membrane components from the debris of dam-
aged neurons. Currently its gene (APOE) has become
one of the most extensive studied genes in neurotrauma
field. apoE contains 299 residues (relative molecular
mass = 34 000) and was originally identified as a main
component of lipoproteins in plasma. All peripheral apoE
is synthesized in the liver, whereas apoE is the prepon-
derant apolipoprotein within the central nervous system
(CNS), where it is primarily synthesized by astrocytes
although neurons and microglia may also contribute to
apoE synthesis. 17,18,19 The human APOE gene is located
on the long arm of chromosome 19 (19q13.2).20,21 The
APOE contains four exons and three introns and is
approximately 3.7 kb in length.21,22  The apoE protein
exists in three major isoforms (apoE2, apoE3 and
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apoE4). After analysis of the amino acid sequences of
these isoforms, single amino acid substitutions at resi-
dues 112 and 158 were found to account for their
differences: apoE2 (Cys112-Cys158), apoE3 (Cys112-
Arg158), and apoE4 (Arg112-Arg158), which are prod-
ucts of alleles at a single polymorphic locus.23,24,25 Neu-
rons receiving apoE3-loaded lipoproteins, which are a
most common isoform compared with those receiving
apoE4-loaded lipoproteins, show significant neurite
extension and branching, suggesting that the effect of
apoE on neurite outgrowth is isoform specific. Studies
of the bioactivity of apoE2 with respect to neuronal
modelling and plasticity suggested that apoE2 appears
to offer protection against AD. The importance of apoE
in neurodegenerative diseases has increased markedly
since the discovery of an association of APOE coding
sequence polymorphisms with late-onset Alzheimer’s
disease (LOAD). 26,27 Furthermore, its potential asso-
ciation with TBI has been postulated, and has become
a focus recently.
An association between APOE genotype, head
injury, and Alzheimer’s disease (AD) was first noticed
by Mayeux et al.28 in 1995 in a study, which suggested
that head injury and APOEε4 genotype acted syner-
gistically to increase the risk of AD in their subjects,
and that a genetic susceptibility is conferred by the
APOEε4 gene and may be exacerbated by an envi-
ronmental risk factor, such as TBI. This finding prompted
further interest to not only the relationship between TBI
and AD, but also the association between apoE and
TBI. The potential association of APOE gene polymor-
phism with the outcome of head injury was first postu-
lated more than 10 years ago. Nicoll et al.29 performed
postmortem examination on the brains of 90 patients
who died of severe TBI to determine whether APOE is
related to amyloid beta-protein (A-beta) deposition in
head injury. The APOE genotype was determined and
subsequently correlated with the neuropathological
findings. 52% of those with beta-amyloid deposition had
an APOE ε4 allele, compared with only 16% of those
without deposition. More importantly, there was a gene-
dose effect; 100% of those with two APOEε4 alleles
(homozygous) had beta-amyloid deposition. It appears
that head injury may trigger deposition of beta-amyloid,
especially in those who have the APOEε4. In addition,
the finding indicates that APOE may increase the ge-
netic susceptibility to the effects of head injury.
Subsequent studies have indicated poor outcome
in APOEε4 carriers for recovery during rehabilitation
after TBI. Sorbi et al.30 reported in a small study that
the APOEε4 was a prognostic factor for posttraumatic
coma. Teasdale et al.6 demonstrated a significant as-
sociation between APOE ε4 and poor outcome in a
preliminary study of 93 patients with head injury, which
showed that patients carrying with the APOEε4 allele
were more than twice as likely to have an unfavorable
outcome 6 months after head injury than those without
APOEε4. More studies have shown a similar
association. Friedman et al.31 reported that only 3.7%
of patients with the APOEε4  allele had a good
recovery, compared with 31% of patients without APOE
ε4. The treatment outcome of patients who were able
to complete a course of neurorehabilitation after TBI
was also found to be associated with APOE genotype.
Motor recovery, as assessed by the Functional Inde-
pendence Measure, was both significantly lower in pa-
tients who possessed the APOE ε4 allele than those
without. 32 Crawford et al. 33 in a study of 110 active and
veteran American military personnel, further found that
although all patients displayed impaired performance
in memory test using some memory and cognitive
measures, those who carried theε4 allele had worse
memory after TBI as well as poorer outcome. In addi-
tion to influencing overall outcome, APOE may also
influence various clinical aspects of TBI, including more
marked cerebral oedema, 34 increased hematoma
volume, 35 greater incidence of moderate/severe contu-
sion injury and severe ischemic brain damage, 36 and
higher in-hospital mortality. 37
Most reports documenting the effect of the APOE
ε4 on TBI outcome have been performed almost ex-
clusively in white populations or those derived from
Caucasus individuals. However, there are still some
studies showing little or insignificant effect of APOE
genotype on outcome. Nathoo et al. 38 reported that there
was a nonsignificant trend between theε4 allele and
outcome in a sample of 110 black Zulu-speaking pa-
tients with cerebral contusions. The differences are
thought to be a result of possible gene-environment in-
teractions that modify the response to different types
of TBI or in different race populations. Whereas Chiang
et al39 extended the findings of the above studies to a
Chinese population in Taiwan. One hundred consecu-
tive patients admitted with TBI were prospectively fol-
lowed until 6 months after injury. More than twice as
Chinese Journal of Traumatology 2008; 11(4):247-252. 250 .
many patients withε4 had an unfavorable outcome at
that stage than those without. The above-mentioned
studies lead other researches to extend the investiga-
tion to the mainland Chinese population. A study car-
ried out by our research group prospectively identified
admissions to the two neurosurgical departments for
head injury. A total of 110 subjects with TBI were en-
rolled to elucidate the relationship between APOE poly-
morphisms and TBI. The data have shown that patients
with APOE ε4 predispose to clinical deterioration in
acute phase after TBI, suggesting APOE polymorphisms
may play a role in early responses to TBI.8,40 This study
is the first ever study to demonstrate the genetic corre-
lation between APOE polymorphisms and the severity
of TBI in mainland Chinese patients and it is surprising
that the effect of APOE seems to be greater in early
stage of TBI in our study focusing primarily on the role
of APOEε4 in outcome after head injury. Although
above researches indicated that APOEε4 is a poor
prognosis factor of TBI, another research in China indi-
cated that APOE ε2 allele and APOEε2/ε3 may be
an indicator for poor prognosis of TBI patients.41 In this
study, 94 TBI patients suffering from hemorrhage were
diagnosed and randomly selected. Frequency of APOE
ε2 (0.1970) allele and APOEε2/ε3 (0.1970) in dead
group was significantly higher than in those cases who
had good recovery. This is different from other findings,
and the reason may be that most of studies have fo-
cused on the association between APOE gene poly-
morphisms and clinical status in all types of TBI in-
cluding mild head injury, intracranial hemorrhage and
so on, whereas Gu et al.41 analyzed the relationship of
APOE polymorphisms with outcome only in intracra-
nial hemorrhage patients who suffering TBI. Although
Xiao et al.42 found that APOEε2 might be a genetic
factor of recurrent lobar cerebral hemorrhage, most of
studies indicate that APOEε4 does work in increas-
ing the hematoma volume and might be an important
factor influencing the prognosis of the Chinese patients
with TBI. 43,44 On the other hand, sample and regional
differences may also influence the association between
gene and TBI. Further larger Chinese cohorts studies
are needed to carry out and elucidate the mechanisms
involving why the APOE allele can adversely affect the
outcome after TBI.
Furthermore, several polymorphisms within the pro-
moter region of the APOE gene have been identified at
-491 (A/T transversion), -427 (T/C transversion), and -
219 (G/T transversion), which may affect the transcrip-
tional activity of the APOE gene.45 Studies focusing on
the polymorphisms within the promoter region demon-
strated that some APOE promoters may increase
APOE expression and exacerbate the response to TBI.
A study by Lendon et al.46 investigated three promoter
polymorphisms (-491 A/T, -427 C/T, -219 G/T) and found
a poorer outcome in -219 G/T carriers. Our latest study
in the Chinese population has shown that only APOE -
491AA promoter in ε4 carriers, as a significant but not
independent risk factor, is apt to clinical deterioration
and may contribute to the poor outcome after TBI.47
Although some studies indicated that APOE genotype
might influence the outcome and/or severity of TBI via
cerebrovascular pathology,36,42,43,44 our data do not sup-
port the hypothesis that genetic variations within the
APOE gene are associated with CT worsening (the ra-
diographic evidence of hemorrhage extension or delayed
hemorrhage) at early stage of TBI in this Chinese popu-
lation study. These findings imply that, in addition to
the qualitative effects of the APOE alleles, the quanti-
tative variation of isoform expression due to polymor-
phisms in the proximal promoter may contribute to dif-
ferent degrees of severity clinical status or outcome
after TBI and may help explain why some individuals
carrying two APOEε 4 alleles can escape such
deterioration.
In general, a series of studies suggests thatε4 al-
lele may exert not only long-term influences manifested
later during the potential recovery phase but also short-
term effects on TBI by worsening the pathological
course of TBI in acute stage. But the results of current
studies are remaining controversial. Perhaps, other fac-
tors (such as gene or genome; protein or proteome)
may play an independent role or synergistic effect in
the severity or outcome following TBI and further work
is required.
Conclusion
Although TBI has been the hot subject in neurosur-
gery research for many years, studies of the genetic
influences on the severity and outcome following TBI is
still at a primary stage. There still has been a dispute
about the association between genetic factors and TBI
in academic field. The concept of genetic susceptibility
to traumatic brain injury can be recognized by more
and more people as the evidences from the clinic and
experimental researches emerge. APOE gene has be-
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come one of the most extensive studied genes in
neurotrauma and neurodegenerative disease. But its
exact molecular mechanism has not been totally
ascertained. Further larger cohorts studies are needed
to elucidate the mechanisms involved. The effects of
gene, such as TNF-α, IL-1α, IL-1β, etc, on out-
come of a number of other acute neurologic conditions
are being explored. There is still a need for larger pro-
spective studies looking at larger panels of gene
polymorphisms. Obviously, it is just the first step to
discover such genetic factors that may influence the
prognosis of TBI through allelic association studies.
Increasing the knowledge of the nature of TBI, deepen-
ing the understanding of the relationship between TBI and
genetics and studies of multiple gene(s) or protein(s) in
larger cohorts, rather than the single gene studies cur-
rently performed, are urgently required.
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